« Back to Client Directory

Reniguard Life Sciences

Bucks County, Life Sciences Sector, Commercialization Portfolio
www.reniguard.com/

PCR clamps proposed can detect mutations in the presence of ≥100-fold excess of wild type (WT) DNA. This technology will allow the detection of microbial mutations in microbiology (i.e., HBV- hepatitis) or colon cancer and other genetic diseases. The technology will be used for microbiology diagnostics and/ or Drug therapy.

University Partners: Institute for Hepatitis and Virus Research

MODANeat CompanyMolecular DetectionCoats AnalyticsClick EquationsClear AlignBioNano GenomicsScience CenterBio AdvanceDVIRCNFTEPennsylvania BIOPhilly Startup LeadersSELECT Greater Philadelphia